Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose Control with Liraglutide During Elective Hip Surgery
2011-004955-38Phase 3Active
- Sponsor
- AMC Health
- Start
- Oct 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of liraglutide in hyperglycemia and Coagulation activation (2 arms), sponsored by AMC Health. Primary endpoint: Mean blood glucose difference. Started Oct 2011; status: active.
02
Drugs
03
Conditions
hyperglycemiaCoagulation activation
Beyond the preview
Go deeper on 2011-004955-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004955-38.